Delayed diagnosis of Duchenne muscular dystrophy in Chile;Tardanza en el diagnóstico de la distrofia muscular de Duchenne en Chile

Revista Medica de Chile

Volumn 127, Issue 1, 1999, Pages 65-70

  Avaria B, María De Los Angeles ^b   Kleinsteuber S, Karin ^a   Herrera C, Luisa ^b   Carvallo de SQ, Pilar ^b  

^a Oficina 706   (Chile)

^b NONE

Author keywords

Creatine kinase; Duchenne muscular dystrophy; Mental retardation; Newborns

Indexed keywords

EID: 0041720385     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. KUNKEL LM, HEJTMANCIK JF, CASKEY CT, SPEER A, MONACO AP, MIDDLESWORTH W ET AL. Analysis of deletions in the DNA of patients with Becker and Duchenne muscular dystrophy. Nature 1986; 322: 73-7.
2. HOFFMAN EP, BROWN RH, KUNKEL LM. Dystrophin: the protein product of Duchenne muscular dystrophy locus. Cell 1987; 51: 919-28.
3. DUCHENNE DE BOULOGNE GBA. De l'electrisation localisee et de son application a la patologie et a la therapeutique. Edition 2. Paris, Bailliere et Fils, 1861.
4. DUCHENNE DE BOULOGNE GBA. De l'electrisation localisee et de son application a la patologie et a la therapeutique. Edition 3. Paris, Bailliere et Fils, 1861.
5. DUCHENNE DE BOULOGNE GBA. Recherches sur la paralysie musculaire pseudo-hypertrophique, ou paralysie myo-sclerosique. Arch Gen Med 1868; 11: 5-25, 179-209, 305-321, 421-343, 551-388. Selección traducida en: Wiikins RH, Brody IA, eds: Neurological Classic. New York, Johnson Reprint 1973; 59-104.
6. DUCHENNE DE BOULOGNE GBA. Recherches sur la paralysie musculaire pseudo-hypertrophique, ou paralysie myo-sclerosique. Arch Gen Med 1868; 11: 5-25, 179-209, 305-321, 421-343, 551-388. Selección traducida en: Wiikins RH, Brody IA, eds: Neurological Classic. New York, Johnson Reprint 1973; 59-104.
7. SCHEUERBRANDT G, LUNDIN A, LOVGREN T. Screening for Duchenne muscular dystrophy: an improved screening test for creatine kinasa and its application in an infant screening program. Muscle Nerve 1986; 9: 11-5.
8. MILLER RG, HOFFMAN EP. Molecular diagnosis and modern management of Duchenne muscular dystrophy. Neurologic Clinics 1994; 12: 699-724.
9. HYSER CL, MENDELL JR. Recent advances in Duchenne and Becker muscular dystrophy. Neurologic Clinics 1988; 6: 429-53.
10. SWAIMAN KF, SMITH SA. Progressive muscular dystrophies. En: Swaiman KF, ed. Pediatric Neurology, Mosby-Year Book, Inc. 1994; 2: 1477-87.
11. MONACO AP, NEVE RL, COLLETTI-FENNER CA, BERTELSON CJ, KURNOT DM, KUNKEL LM. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 1986; 323: 646-50.
12. HOFFMAN EP. Molecular diagnostics of Duchenne/ Becker dystrophy: new additions to a rapidly expanding literature. J Neurol Sci 1991; 101: 129-32.
13. OHLENDIECK K, MATSUMURA K, IONASESCU W, TOWBIN JA, BOSH EP, WEINSTEIN SL ET AL. Duchenne muscular dystrophy: deficiency of dystrophyn-associated proteins in the sarcolemma. Neurology 1993; 43: 795-800.
14. BROWNELL AKW, PAASUKE RT, ELASH A. Malignant hyperthermia in Duchenne muscular dystrophy. Anesthesiology 1983; 58: 180-2.
15. WANG JM, STANLEY TH. Duchenne muscular dystrophy and malignant hyperthermia-two cases reports. Can Anaesth Soc J 1986; 33: 492-7.
16. LARSEN UT, JUHL B, SORENSEN OH, OLIVARIUS BDF. Complications during anaesthesia in patients with Duchenne's muscular dystrophy (a retrospective study). Can J Anaesth 1989; 36: 418-22.
17. BOLTSHAUSER E, STEINMANN B, MEYER A, JERUSALEM F. Anaesthesia-induced rhabdomyolysis in Duchenne muscular dystrophy. Br J Anaesth 1980; 52: 559-64.
18. GREENBERG CR, JACOBS HK, HALLIDAY W. Three years' experience with neonatal screening for Duchenne/Becker muscular dystrophy: Gene analysis, gene expression and phenotype prediction. Am J Med Genet 1991; 39: 68-72.
19. NAYLOR EW, HOFFMAN EP, PAULUS-THOMAS J. Neonatal screening for Duchenne/Becker muscular dystrophy: Reconsideration based on molecular diagnosis and potential therapeutics. Screening 1992; 1: 99-103.
20. MILLER G, WESSEL HB. Diagnosis of dystrophinopathies: Review for the clinician. Pediatr Neurol 1993; 9: 3-9.
21. VAINZOF M, ZUBRZYCKA-GAARN EE, RAPAPORT D, PASOS-BUENO MR, PAVANELLO RCM, PAVANELLO-FILHO I ET AL. Immunofluorescence dystrophin study in Duchenne dystrophy trough the concomitant use of two antibodies directed against the carboxy-terminal and the amino-terminal region of the protein. J Neural Sci 1991; 101: 141-7.
22. BEGGS AH, KOENIG H, BOYCE FM, KUNKEL LM. Detection of 98% of DMD/DMB gene deletions by polymerase chain reaction. Human Genet 1990; 86 :45-8.
23. BROOKE MH. Motor unit weakness. En: Bradley WG, Daroff RB, Fenichel GM, Mardsen CD, eds. Neurology in Clinical Practice. Butterworth-Heinemann, Boston, 1991; 2: 275-88.
24. WHELAN TB. Neuropsychological performance of children with Duchenne muscular dystrophy and Spinal Muscle Atrophy. Develop Med Child Neurol 1987; 29: 212-20.
25. PROSSER EJ, MURPHY EG, THOMPSON MW. Intelligence and the gene for Duchenne muscular dystrophy. Arch Dis Childh 1969; 44: 221-30.